• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.炎症性肠病成年患者接种SARS-CoV-2 mRNA疫苗后的抗体反应
Ann Intern Med. 2021 Dec;174(12):1768-1770. doi: 10.7326/M21-2483. Epub 2021 Oct 12.
2
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases.肝病人群接种 SARS-CoV-2 疫苗后的抗体反应。
Viruses. 2022 Jan 21;14(2):207. doi: 10.3390/v14020207.
3
Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals.初次感染和既往感染新冠病毒个体对SARS-CoV-2感染及疫苗接种的抗体反应
Viruses. 2022 Feb 10;14(2):370. doi: 10.3390/v14020370.
4
Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.评估新冠疫苗需要标准化的中和抗体检测。
EBioMedicine. 2021 Nov;73:103677. doi: 10.1016/j.ebiom.2021.103677. Epub 2021 Nov 3.
5
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.一项评估 mRNA SARS-CoV-2 疫苗在希腊患有系统性自身免疫和自身炎症性风湿性疾病的患者中的体液免疫原性和安全性的前瞻性多中心研究。
J Autoimmun. 2021 Dec;125:102743. doi: 10.1016/j.jaut.2021.102743. Epub 2021 Oct 28.
6
Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants.疫苗诱导产生的抗体水平与针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其变体的中和活性之间的相关性。
Clin Transl Med. 2021 Dec;11(12):e644. doi: 10.1002/ctm2.644.
7
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.SARS-CoV-2 mRNA 疫苗接种后的抗体亲和力成熟和跨变体活性：既往暴露和性别的影响。
EBioMedicine. 2021 Dec;74:103748. doi: 10.1016/j.ebiom.2021.103748. Epub 2021 Dec 10.
8
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.接受生物疗法的炎症性肠病患者对2019冠状病毒病信使核糖核酸疫苗的血清学反应
Gastroenterology. 2021 Aug;161(2):715-718.e4. doi: 10.1053/j.gastro.2021.04.025. Epub 2021 Apr 20.
9
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.美国五家退伍军人事务医疗中心 2021 年 2 月 1 日至 9 月 30 日期间住院退伍军人中 Moderna 和辉瑞-BioNTech COVID-19 疫苗的有效性和抗体反应比较。
MMWR Morb Mortal Wkly Rep. 2021 Dec 10;70(49):1700-1705. doi: 10.15585/mmwr.mm7049a2.
10
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.mRNA 疫苗接种对多发性骨髓瘤患者 COVID-19 的反应。
Leukemia. 2021 Dec;35(12):3534-3541. doi: 10.1038/s41375-021-01354-7. Epub 2021 Jul 29.

引用本文的文献

1
Remote Monitoring for Patients With Inflammatory Bowel Disease: Current Status and the Future of the Field.炎症性肠病患者的远程监测：该领域的现状与未来
Gastroenterol Hepatol (N Y). 2024 Oct;20(10):621-627.
2
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.新型冠状病毒肺炎与炎症性肠病实用最新进展：新型冠状病毒肺炎疾病风险及疫苗安全性与有效性
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
3
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.接受抗肿瘤坏死因子治疗的炎症性肠病患者接种3剂mRNA新冠疫苗后产生更高且持续的细胞介导免疫反应。
Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00688. doi: 10.14309/ctg.0000000000000688.
4
Serum Anti-Spike Antibodies Are Not Affected by Immunosuppressants in SARS-CoV-2 Vaccinations Given to Brazilian Patients with Inflammatory Bowel Disease.在为巴西炎症性肠病患者接种的新冠疫苗中，血清抗刺突抗体不受免疫抑制剂影响。
Healthcare (Basel). 2023 Oct 19;11(20):2767. doi: 10.3390/healthcare11202767.
5
Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving -TNF therapy: A systematic review and meta-analysis.新冠病毒疫苗在接受肿瘤坏死因子治疗的炎症性肠病患者中的疗效：一项系统评价和荟萃分析。
Heliyon. 2023 Sep 5;9(9):e19609. doi: 10.1016/j.heliyon.2023.e19609. eCollection 2023 Sep.
6
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.炎症性肠病患者接种第四剂 SARS-CoV-2 mRNA 疫苗后的接种后症状
Inflamm Bowel Dis. 2024 Aug 1;30(8):1430-1434. doi: 10.1093/ibd/izad198.
7
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination.一种增强表位的方法，用于确定 SARS-CoV-2 疫苗接种后私人人类 T 细胞疫苗反应的广度和深度 TCR 克隆指标。
Int J Mol Sci. 2023 Sep 18;24(18):14223. doi: 10.3390/ijms241814223.
8
COVID-19 vaccination in adults with inflammatory bowel disease.炎症性肠病成年患者的新冠病毒疫苗接种
Therap Adv Gastroenterol. 2023 May 22;16:17562848231173130. doi: 10.1177/17562848231173130. eCollection 2023.
9
The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions.新冠疫情对炎症性肠病患者的影响：经验教训与未来方向
J Clin Med. 2022 Nov 27;11(23):7002. doi: 10.3390/jcm11237002.
10
COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.炎症性肠病患者的新冠病毒疫苗接种：认知、疗效与安全性
Gastroenterol Hepatol (N Y). 2022 Jul;18(7):388-399.

Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.

作者信息

Melmed Gil Y, Botwin Gregory J, Sobhani Kimia, Li Dalin, Prostko John, Figueiredo Jane, Cheng Susan, Braun Jonathan, McGovern Dermot P B

机构信息

Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

Ann Intern Med. 2021 Dec;174(12):1768-1770. doi: 10.7326/M21-2483. Epub 2021 Oct 12.

DOI:10.7326/M21-2483
PMID:34633830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8513793/
Abstract
摘要